Lenz Therapeutics: Funding, Investors & Team (Oct 2026)
LENZ Therapeutics is a late-stage clinical startup creating novel, vision-improving ophthalmic prescription medicines. Our main program is an eye drop with aceclidine to treat presbyopia-related loss of near vision. More than 120 million people in the US and about two billion people worldwide are affected by presbyopia. LENZ Therapeutics is based in San Diego, California, and is supported by a number of prestigious venture capitalists.
Lenz Therapeutics has raised $49.0M across 1 funding round on record, the most recent an undisclosed round of $49.0M announced in Nov 2022.
That round is above the $38M median round size for Pharmaceutical Manufacturing companies tracked on FundedIQ over the last two years.
Lenz Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Lenz Therapeutics Funding Rounds
Lenz Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Lenz Therapeutics Funding Compared to Other Pharmaceutical Manufacturing Startups
Lenz Therapeutics' latest round of $49.0M is above the median round in Pharmaceutical Manufacturing. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lenz Therapeutics in Pharmaceutical Manufacturing and Del Mar
Companies Similar to Lenz Therapeutics
India Globalization Capital, Inc. (IGC) operates as a materials and infrastructure company in India and…
Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.
Corsair Pharma aims to revolutionize the therapeutic characteristics of medications, delivering enhanced…
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development.
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…
Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…
PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…
Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…
Insuraviews provides software for analyzing insurance rate filings with search, analytics, and competitive…
Thrixel is an AI-powered 3D model generation platform designed to integrate directly with coding agents, AI…
Vye Health is an AI-native healthcare company that provides tools for medical providers to launch and run…
Lenz Therapeutics Funding FAQs
What does Lenz Therapeutics do?
LENZ Therapeutics is a late-stage clinical startup creating novel, vision-improving ophthalmic prescription medicines. Our main program is an eye drop with aceclidine to treat presbyopia-related loss of near vision. More than 120 million people in the US and about two billion people worldwide are affected by presbyopia. LENZ Therapeutics is based in San Diego, California, and is supported by a number of prestigious venture capitalists.
How much funding has Lenz Therapeutics raised?
Lenz Therapeutics has raised $49.0M across 1 round on record. The most recent is an undisclosed round of $49.0M announced in Nov 2022.
When did Lenz Therapeutics last raise funding?
Lenz Therapeutics' most recent funding round on record is an undisclosed round of $49.0M, announced in Nov 2022.
Who is the CEO of Lenz Therapeutics?
Eef Schimmelpennink is listed as CEO at Lenz Therapeutics.
Where is Lenz Therapeutics headquartered?
Lenz Therapeutics is based in Del Mar, California, United States.
How many employees does Lenz Therapeutics have?
Lenz Therapeutics is in the 11-50 employee band.
How does Lenz Therapeutics' funding compare to other Pharmaceutical Manufacturing startups?
Lenz Therapeutics' latest round of $49.0M is above the $38M median round size for Pharmaceutical Manufacturing companies on FundedIQ across 7 tracked companies over the last two years.
About FundedIQ's Lenz Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lenz Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.